Cardinal Health (NYSE:CAH) announced the acquisition of ScalaMed, a HIPAA-compliant, smart platform that transfers prescriptions directly to patients via a secure mobile app. The acquisition transfers ScalaMed’s technology and assets to Outcomes(tm), a Cardinal Health company.
ScalaMed pivots prescription management from provider to patient, allowing patients to send prescriptions written by their provider directly to any pharmacy for the first fill. The platform offers patients greater flexibility, easier access, and price\ comparison to select the pharmacy of their choice.
For providers, the platform eliminates the administrative work of transferring prescriptions, saving the average clinician 40 hours per year. It also helps improve health outcomes with improved adherence and increased patient satisfaction. ScalaMed’s technology will be offered through the Cardinal Health nationwide pharmacy network, creating unprecedented opportunities for digital connectivity to millions of patients.
“As health care continues to evolve toward patient preferences, the acquisition of ScalaMed allows us to center our connected ecosystem around the patient from the outset of their treatment journey – from the doctor’s office to the pharmacy to home,” said Brent Stutz, SVP/GM of Outcomes(tm), a Cardinal Health Company. “Using ScalaMed’s technology, we can better support patients at every step along their treatment journey through unified communication and more informed insights that will help remove access and adherence barriers.”
Built by physicians and pharmacists with first-hand knowledge of how prescriptions are often mismanaged in the current health care system, ScalaMed worked to develop a digital solution that empowered patients and personalized their care, taking into account the real-world challenges of daily life that often lead to medication nonadherence.
“The process of digitizing prescriptions removes the patient from the equation and overlooks the complexity of the real-life adherence challenges patients face – forgetting medication on vacation, not having a pharmacy with convenient hours nearby, the variables are endless,” said Dr. Tal Rapke, MD CEO and Founder of ScalaMed. “We’re excited to partner with a leader in pharmacy like Cardinal Health, so that together, we can offer a solution that is both smart and patient-centric. With the scale and innovation Cardinal Health offers, we can revolutionize how prescriptions are filled and help solve the massive, costly challenge of medication nonadherence.”
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
About ScalaMed
ScalaMed believes in empowering patient-centered healthcare by creating new ways for the healthcare industry to support patients to achieve better health outcomes. We are determined to support, educate, and care for patients by putting their health information at their fingertips for 24/7 access. Leveraging our experienced team of doctors, pharmacists and technology experts, ScalaMed’s technology pivots healthcare to the patient. Learn more at scalamed.com.
The M&A market for healthcare companies continues to strengthen in 2022 with strategic corporate buyers and private equity investors. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering strong valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
